Pentamidine Isethionate Injection shortage

Not a nationwide shortage — XGen Pharmaceuticals DJB has told the FDA it is discontinuing its pentamidine isethionate injections.

  • The FDA lists this under “To be discontinued” as of Nov 21, 2026: a company stopping its own product.
  • 4 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
Status
FDA term: “To Be Discontinued”
Products on the record
1
Category
First posted
Mar 23, 2026
Last updated
Mar 23, 2026

This page is curated, coded, and maintained by ⁠ Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy

Source: FDA Drug Shortages Database API (openFDA). Last refreshed Nov 21, 2026 (today).

The Bottom Line

XGen Pharmaceuticals is permanently stopping its pentamidine isethionate injection. Other manufacturers — including Fresenius Kabi and Seton Pharmaceuticals — still list this medicine, including Pentam 300 (pentamidine isethionate) 300 mg, so supply may be available from other sources.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Is Pentamidine Isethionate Being Discontinued? Status as of Nov 21, 2026

Not as a whole, as of Nov 21, 2026. XGen Pharmaceuticals DJB is stopping its own version only; 4 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.

Supply Risk: Low

0 of 5 risk factors

Your pharmacy can often still get it, though it may need to be ordered. It is our estimate across the country, not a check of your pharmacy’s shelves.

Which of the Five Risk Factors Apply

  • A strength with no makerThe one strength on the record is still made by a company. Does not apply
  • Down to one company4 companies may still have it: the one company that reported the shortage reports no supply, and 4 more have not reported a problem. Does not apply
  • Most products unavailableThe FDA’s list gives no count, but at least one company may still have it. Does not apply
  • Over three monthsThis is a discontinuation notice, which does not count as an outage. Does not apply
  • Few companies make it5 companies make it: 1 that reported the shortage and 4 that have not. Does not apply

What each rating means ↓

The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.

Availability of the Affected Products

From the FDA shortage report: 1 product

  • 1

Is Every Strength Still Made?

A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.

1 of 1 strength

  • 300 mg/3 mLStill made by a company

Other Companies Listing the Same Medicine, Not Reporting a Shortage

Companies that list Pentamidine Isethionate Injection with the FDA and have not reported a shortage (not counted in the charts above).

  • PAI Holdings, LLC dba PAI Pharma
  • Seton Pharmaceuticals
  • Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
  • Fresenius Kabi USA, LLC

Plus 4 other dosage forms of pentamidine isethionate.

See all other options & details ↓

Shortage Timeline

  1. Mar 23, 2026 Discontinuation notice on file 1 of 1 product affected.
  2. Mar 23, 2026 First reported to the FDA 1 product first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

Which Pentamidine Isethionate Products Are Affected, by Company

Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get pentamidine isethionate?).

Company: XGen Pharmaceuticals DJB, Inc. 1 product · 866-390-4411
  • Pentamidine Isethionate Injection, 300 mg/3 mL

    39822-3050-02
    Strength
    300 mg/3 mL
    Availability
    Not stated

    Notes: A business decision was made to discontinue manufacture of the drug.

Why Is XGen Pharmaceuticals DJB Discontinuing Pentamidine Isethionate?

A note from Dr. Brian Staiger, PharmD · Written Oct 7, 2026

XGen Pharmaceuticals has made a business decision to permanently stop making their version of Pentamidine Isethionate Injection 300 mg/3 mL (the vial size identified as NDC 39822-3050-2). No specific reason beyond it being a business decision was shared publicly — they didn't give a more detailed explanation.

It's worth knowing that this report only covers XGen Pharmaceuticals' product. It doesn't mean this medication is going away from every company that makes it — other manufacturers may still be producing their own versions, and those are tracked separately.

What Should I Do If I Take Pentamidine Isethionate?

A note from Dr. Brian Staiger, PharmD · Written Oct 7, 2026

Pentamidine Isethionate Injection is currently on the FDA shortage list. I want to walk you through what this means and the steps you can take.

The one strength involved here is 300 mg/3 mL. The manufacturer reporting this — XGen Pharmaceuticals — has made a business decision to discontinue making it, so this particular supply issue may be permanent rather than temporary. Because this is a planned discontinuation, a conversation with your prescriber or pharmacist is the right next step to plan ahead.

It's important to know this report reflects only the one company that filed it. The same medicine is still listed by other makers, so it may still be obtainable through your pharmacy.

Here is what I suggest, in order:

  • Do not stop, skip, or change your doses on your own.
  • Ask your pharmacy to source this medicine — the same ingredient is also made by PAI Pharma, Seton Pharmaceuticals, Avet Pharmaceuticals, and Fresenius Kabi (Pentam 300). Your pharmacy can check wholesalers and these makers, though a given product may not be in local stock.
  • If your exact product cannot be found, ask your prescriber or pharmacist about a clinician-chosen option.
  • Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls.

This is general, national information and may not match your local pharmacy's actual stock.

Quick checklist for the pharmacy counter

  • Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
  • If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.

Where Else Can I Get Pentamidine Isethionate?

From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage and other dosage forms.

  • Some listings are repackagers, which relabel another company’s product.
  • A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same Medicine From Other Companies (Not Reporting a Shortage)

The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.

ProductStrengthForm / routeCompanyNDC
Pentamidine Isethionate 300 mg/300 mg Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous PAI Holdings, LLC dba PAI Pharma 00121-1101-02
Pentamidine Isethionate 300 mg/300 mg Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous Seton Pharmaceuticals 13925-0515-10
Pentamidine Isethionate 300 mg/300 mg Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0748-41
Pentam 300 300 mg/3 mL Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous Fresenius Kabi USA, LLC 63323-0113-10

Therapeutic Equivalents and Pricing 5 products

Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.

ProductManufacturerPackagePharmacy cost per unit (NADAC)FDA rated equivalentAvailability
Pentamidine Isethionate 300 mg/300mgNDC 00121-1101-02 PAI 10 vials — AP FDA listed
Pentamidine Isethionate 300 mg/300mgNDC 13925-0515-10 Seton 10 vials — AP FDA listed
pentamidine isethionate 300 mg/300mgNDC 23155-0748-41 Heritage 10 vials — AP FDA listed
Pentamidine Isethionate 300 mg/3mLNDC 39822-3050-02 XGen 10 vials — — Discontinued
Pentam 300 300 mg/3mLNDC 63323-0113-10 Fresenius 10 vials — AP FDA listed

These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.

Other Drugs in the Same Treatment Class

These are different medicines — not other versions of pentamidine isethionate — that fall in the same broad treatment class (antiprotozoal drugs,miscellaneous). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Codes & Classification for pharmacists and billers

GCN Seq No
009599
GCN
42990
HICL code
004162
Ingredient (HICL)
Pentamidine Isethionate
HIC1 code
W
Therapeutic class — broad (HIC1)
Anti-Infecting Agents
HIC2 code
W4
Therapeutic class — intermediate (HIC2)
Antiparasitics
HIC3 code
W4K
Therapeutic class — specific (HIC3)
Antiprotozoal Drugs,Miscellaneous
AHFS code
08:30.12.00
AHFS class
Antiprotozoals, P Jirovecii Pneumonia
FDB label name
PENTAMIDINE 300 MG INJECT VIAL
FDB brand name
Pentamidine Isethionate
Legend status
F — Federal legend — prescription drug or device

Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other Anti-Infective Shortages

Pentamidine isethionate Shortage FAQs

Is pentamidine isethionate discontinued?

Only XGen Pharmaceuticals DJB’s version. XGen Pharmaceuticals DJB has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 21, 2026), while 4 other companies still sell the same medicine and have not reported a problem (PAI Holdings, LLC dba PAI Pharma, Seton Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals and 1 more). It is not a nationwide shortage.

Which strengths of pentamidine isethionate are affected?

The FDA record covers 1 strength: 300 mg/3 mL. Every strength on the record is still made by at least one company, though stock varies by pharmacy.

Why is XGen Pharmaceuticals DJB discontinuing pentamidine isethionate?

XGen Pharmaceuticals DJB’s note on the FDA record says: “A business decision was made to discontinue manufacture of the drug.”

Which pentamidine isethionate products are affected?

Pentamidine Isethionate Injection, 300 mg/3 mL (NDC 39822-3050-02). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.

When will pentamidine isethionate be available again?

A discontinuation is usually permanent for that company’s product. The same medicine is still sold by PAI Holdings, LLC dba PAI Pharma, Seton Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals and 1 more, so ask your pharmacy to order another company’s version.

Can I still get pentamidine isethionate somewhere?

Other companies (PAI Holdings, LLC dba PAI Pharma, Seton Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals and 1 more) sell the same medicine and have not reported a problem. 4 other dosage forms of pentamidine isethionate are also listed. See “Where else can I get pentamidine isethionate?” above — stock still varies by pharmacy.

What should I do if I take pentamidine isethionate?

Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.

How to Read the Supply-Risk Rating

Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.

  • Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Pentamidine isethionate is rated Low: 0 of 5 risk factors.
  • Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
  • High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.

Back to this drug’s rating ↑ · How we rate supply risk, in full

Where This Data Comes From

For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.

Back to all current drug shortages